Rodney Nathan

Rodney Nathan, M.D., serves as Partner and Portfolio Manager at J. Goldman & Co., L.P. in New York, where he plays a senior leadership role overseeing investment strategy and portfolio management for the firm. His responsibilities focus extensively on the biotechnology sector, where he is a recognized expert in identifying opportunities and trends that drive growth and value, particularly within public biotech companies.

Dr. Nathan has been with J. Goldman & Co. since 2002, after completing advanced medical training at Columbia Presbyterian Hospital and earning his M.D. from The University of Texas Southwestern Medical Center at Dallas. Prior to that, he graduated with a bachelor's degree in Biology from Washington University in St. Louis, grounding his investment work in a robust scientific and analytical foundation.

A frequent speaker at industry panels, Dr. Nathan is noted for his insights into biopharma capital markets and for helping guide J. Goldman & Co.'s investment approach through volatile market cycles. His expertise connects deep sector knowledge in biotechnology with financial market acumen, positioning him as a leader in healthcare investing for institutional clients and stakeholders.